Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
The pregnenolone-derivative MAP4343: a new treatment of depression: preclinical project
| Reference number | 2010-02629 |
| Coordinator | Karolinska institutet - Institutionen för klinisk neurovetenskap |
| Funding from Vinnova | SEK 810 000 |
| Project duration | January 2011 - August 2013 |
| Status | Completed |
